Global Radiopharmaceuticals for Therapeutic Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Radiopharmaceuticals for Therapeutic market size was valued at USD 1822.3 million in 2023 and is forecast to a readjusted size of USD 4687.5 million by 2030 with a CAGR of 14.5% during review period.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Radiopharmaceuticals for Therapeutic industry chain, the market status of Thyroid (Radium-223, Lutetium-177), Bone Metastasis (Radium-223, Lutetium-177), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radiopharmaceuticals for Therapeutic.

Regionally, the report analyzes the Radiopharmaceuticals for Therapeutic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radiopharmaceuticals for Therapeutic market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Radiopharmaceuticals for Therapeutic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radiopharmaceuticals for Therapeutic industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Radium-223, Lutetium-177).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radiopharmaceuticals for Therapeutic market.

Regional Analysis: The report involves examining the Radiopharmaceuticals for Therapeutic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radiopharmaceuticals for Therapeutic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Radiopharmaceuticals for Therapeutic:
Company Analysis: Report covers individual Radiopharmaceuticals for Therapeutic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radiopharmaceuticals for Therapeutic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Thyroid, Bone Metastasis).

Technology Analysis: Report covers specific technologies relevant to Radiopharmaceuticals for Therapeutic. It assesses the current state, advancements, and potential future developments in Radiopharmaceuticals for Therapeutic areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radiopharmaceuticals for Therapeutic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Radiopharmaceuticals for Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other

Market segment by Application
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

Market segment by players, this report covers
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant Radiopharma
    Lantheus
    Aurobindo Pharma
    International Isotopes
    Mundipharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radiopharmaceuticals for Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radiopharmaceuticals for Therapeutic, with revenue, gross margin and global market share of Radiopharmaceuticals for Therapeutic from 2019 to 2024.
Chapter 3, the Radiopharmaceuticals for Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Radiopharmaceuticals for Therapeutic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals for Therapeutic.
Chapter 13, to describe Radiopharmaceuticals for Therapeutic research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Radiopharmaceuticals for Therapeutic
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Radiopharmaceuticals for Therapeutic by Type
        1.3.1 Overview: Global Radiopharmaceuticals for Therapeutic Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type in 2023
        1.3.3 Radium-223
        1.3.4 Lutetium-177
        1.3.5 Iodine-131
        1.3.6 Other
    1.4 Global Radiopharmaceuticals for Therapeutic Market by Application
        1.4.1 Overview: Global Radiopharmaceuticals for Therapeutic Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Thyroid
        1.4.3 Bone Metastasis
        1.4.4 Lymphoma
        1.4.5 Other
    1.5 Global Radiopharmaceuticals for Therapeutic Market Size & Forecast
    1.6 Global Radiopharmaceuticals for Therapeutic Market Size and Forecast by Region
        1.6.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Radiopharmaceuticals for Therapeutic Market Size by Region, (2019-2030)
        1.6.3 North America Radiopharmaceuticals for Therapeutic Market Size and Prospect (2019-2030)
        1.6.4 Europe Radiopharmaceuticals for Therapeutic Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size and Prospect (2019-2030)
        1.6.6 South America Radiopharmaceuticals for Therapeutic Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Radiopharmaceuticals for Therapeutic Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Radiopharmaceuticals for Therapeutic Product and Solutions
        2.1.4 Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Radiopharmaceuticals for Therapeutic Product and Solutions
        2.2.4 Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 China Isotope & Radiation
        2.3.1 China Isotope & Radiation Details
        2.3.2 China Isotope & Radiation Major Business
        2.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Solutions
        2.3.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 China Isotope & Radiation Recent Developments and Future Plans
    2.4 Dongcheng
        2.4.1 Dongcheng Details
        2.4.2 Dongcheng Major Business
        2.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Product and Solutions
        2.4.4 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Dongcheng Recent Developments and Future Plans
    2.5 Q BioMed
        2.5.1 Q BioMed Details
        2.5.2 Q BioMed Major Business
        2.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Product and Solutions
        2.5.4 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Q BioMed Recent Developments and Future Plans
    2.6 Curium Pharmaceuticals
        2.6.1 Curium Pharmaceuticals Details
        2.6.2 Curium Pharmaceuticals Major Business
        2.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
        2.6.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Curium Pharmaceuticals Recent Developments and Future Plans
    2.7 Jubilant Radiopharma
        2.7.1 Jubilant Radiopharma Details
        2.7.2 Jubilant Radiopharma Major Business
        2.7.3 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product and Solutions
        2.7.4 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Jubilant Radiopharma Recent Developments and Future Plans
    2.8 Lantheus
        2.8.1 Lantheus Details
        2.8.2 Lantheus Major Business
        2.8.3 Lantheus Radiopharmaceuticals for Therapeutic Product and Solutions
        2.8.4 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Lantheus Recent Developments and Future Plans
    2.9 Aurobindo Pharma
        2.9.1 Aurobindo Pharma Details
        2.9.2 Aurobindo Pharma Major Business
        2.9.3 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product and Solutions
        2.9.4 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Aurobindo Pharma Recent Developments and Future Plans
    2.10 International Isotopes
        2.10.1 International Isotopes Details
        2.10.2 International Isotopes Major Business
        2.10.3 International Isotopes Radiopharmaceuticals for Therapeutic Product and Solutions
        2.10.4 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 International Isotopes Recent Developments and Future Plans
    2.11 Mundipharma
        2.11.1 Mundipharma Details
        2.11.2 Mundipharma Major Business
        2.11.3 Mundipharma Radiopharmaceuticals for Therapeutic Product and Solutions
        2.11.4 Mundipharma Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Mundipharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Radiopharmaceuticals for Therapeutic Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Radiopharmaceuticals for Therapeutic by Company Revenue
        3.2.2 Top 3 Radiopharmaceuticals for Therapeutic Players Market Share in 2023
        3.2.3 Top 6 Radiopharmaceuticals for Therapeutic Players Market Share in 2023
    3.3 Radiopharmaceuticals for Therapeutic Market: Overall Company Footprint Analysis
        3.3.1 Radiopharmaceuticals for Therapeutic Market: Region Footprint
        3.3.2 Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
        3.3.3 Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Radiopharmaceuticals for Therapeutic Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Radiopharmaceuticals for Therapeutic Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2024)
    5.2 Global Radiopharmaceuticals for Therapeutic Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2030)
    6.2 North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2030)
    6.3 North America Radiopharmaceuticals for Therapeutic Market Size by Country
        6.3.1 North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2030)
        6.3.2 United States Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        6.3.3 Canada Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        6.3.4 Mexico Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2030)
    7.2 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2030)
    7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Country
        7.3.1 Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2030)
        7.3.2 Germany Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        7.3.3 France Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        7.3.5 Russia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        7.3.6 Italy Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region
        8.3.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2019-2030)
        8.3.2 China Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        8.3.3 Japan Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        8.3.4 South Korea Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        8.3.5 India Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        8.3.7 Australia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2030)
    9.2 South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2030)
    9.3 South America Radiopharmaceuticals for Therapeutic Market Size by Country
        9.3.1 South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2030)
        9.3.2 Brazil Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        9.3.3 Argentina Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country
        10.3.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2030)
        10.3.2 Turkey Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)
        10.3.4 UAE Radiopharmaceuticals for Therapeutic Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Radiopharmaceuticals for Therapeutic Market Drivers
    11.2 Radiopharmaceuticals for Therapeutic Market Restraints
    11.3 Radiopharmaceuticals for Therapeutic Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Radiopharmaceuticals for Therapeutic Industry Chain
    12.2 Radiopharmaceuticals for Therapeutic Upstream Analysis
    12.3 Radiopharmaceuticals for Therapeutic Midstream Analysis
    12.4 Radiopharmaceuticals for Therapeutic Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Radiopharmaceuticals for Therapeutic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Radiopharmaceuticals for Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Radiopharmaceuticals for Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Bayer Company Information, Head Office, and Major Competitors
    Table 6. Bayer Major Business
    Table 7. Bayer Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 8. Bayer Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Bayer Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 13. Novartis Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. China Isotope & Radiation Company Information, Head Office, and Major Competitors
    Table 16. China Isotope & Radiation Major Business
    Table 17. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 18. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. China Isotope & Radiation Recent Developments and Future Plans
    Table 20. Dongcheng Company Information, Head Office, and Major Competitors
    Table 21. Dongcheng Major Business
    Table 22. Dongcheng Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 23. Dongcheng Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Dongcheng Recent Developments and Future Plans
    Table 25. Q BioMed Company Information, Head Office, and Major Competitors
    Table 26. Q BioMed Major Business
    Table 27. Q BioMed Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 28. Q BioMed Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Q BioMed Recent Developments and Future Plans
    Table 30. Curium Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Curium Pharmaceuticals Major Business
    Table 32. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 33. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Curium Pharmaceuticals Recent Developments and Future Plans
    Table 35. Jubilant Radiopharma Company Information, Head Office, and Major Competitors
    Table 36. Jubilant Radiopharma Major Business
    Table 37. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 38. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Jubilant Radiopharma Recent Developments and Future Plans
    Table 40. Lantheus Company Information, Head Office, and Major Competitors
    Table 41. Lantheus Major Business
    Table 42. Lantheus Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 43. Lantheus Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Lantheus Recent Developments and Future Plans
    Table 45. Aurobindo Pharma Company Information, Head Office, and Major Competitors
    Table 46. Aurobindo Pharma Major Business
    Table 47. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 48. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Aurobindo Pharma Recent Developments and Future Plans
    Table 50. International Isotopes Company Information, Head Office, and Major Competitors
    Table 51. International Isotopes Major Business
    Table 52. International Isotopes Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 53. International Isotopes Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. International Isotopes Recent Developments and Future Plans
    Table 55. Mundipharma Company Information, Head Office, and Major Competitors
    Table 56. Mundipharma Major Business
    Table 57. Mundipharma Radiopharmaceuticals for Therapeutic Product and Solutions
    Table 58. Mundipharma Radiopharmaceuticals for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Mundipharma Recent Developments and Future Plans
    Table 60. Global Radiopharmaceuticals for Therapeutic Revenue (USD Million) by Players (2019-2024)
    Table 61. Global Radiopharmaceuticals for Therapeutic Revenue Share by Players (2019-2024)
    Table 62. Breakdown of Radiopharmaceuticals for Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Radiopharmaceuticals for Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 64. Head Office of Key Radiopharmaceuticals for Therapeutic Players
    Table 65. Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
    Table 66. Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    Table 67. Radiopharmaceuticals for Therapeutic New Market Entrants and Barriers to Market Entry
    Table 68. Radiopharmaceuticals for Therapeutic Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Radiopharmaceuticals for Therapeutic Consumption Value (USD Million) by Type (2019-2024)
    Table 70. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Type (2019-2024)
    Table 71. Global Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Type (2025-2030)
    Table 72. Global Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024)
    Table 73. Global Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Application (2025-2030)
    Table 74. North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
    Table 75. North America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
    Table 76. North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. North America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
    Table 79. North America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
    Table 80. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
    Table 83. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
    Table 84. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Radiopharmaceuticals for Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
    Table 87. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
    Table 88. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
    Table 89. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
    Table 90. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
    Table 91. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
    Table 92. South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
    Table 93. South America Radiopharmaceuticals for Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
    Table 94. South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
    Table 95. South America Radiopharmaceuticals for Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
    Table 96. South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. South America Radiopharmaceuticals for Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
    Table 100. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
    Table 101. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
    Table 103. Middle East & Africa Radiopharmaceuticals for Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
    Table 104. Radiopharmaceuticals for Therapeutic Raw Material
    Table 105. Key Suppliers of Radiopharmaceuticals for Therapeutic Raw Materials
List of Figures
    Figure 1. Radiopharmaceuticals for Therapeutic Picture
    Figure 2. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type in 2023
    Figure 4. Radium-223
    Figure 5. Lutetium-177
    Figure 6. Iodine-131
    Figure 7. Other
    Figure 8. Global Radiopharmaceuticals for Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application in 2023
    Figure 10. Thyroid Picture
    Figure 11. Bone Metastasis Picture
    Figure 12. Lymphoma Picture
    Figure 13. Other Picture
    Figure 14. Global Radiopharmaceuticals for Therapeutic Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Radiopharmaceuticals for Therapeutic Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Market Radiopharmaceuticals for Therapeutic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 17. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region (2019-2030)
    Figure 18. Global Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region in 2023
    Figure 19. North America Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 20. Europe Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 21. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 22. South America Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 23. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 24. Global Radiopharmaceuticals for Therapeutic Revenue Share by Players in 2023
    Figure 25. Radiopharmaceuticals for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 26. Global Top 3 Players Radiopharmaceuticals for Therapeutic Market Share in 2023
    Figure 27. Global Top 6 Players Radiopharmaceuticals for Therapeutic Market Share in 2023
    Figure 28. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Type (2019-2024)
    Figure 29. Global Radiopharmaceuticals for Therapeutic Market Share Forecast by Type (2025-2030)
    Figure 30. Global Radiopharmaceuticals for Therapeutic Consumption Value Share by Application (2019-2024)
    Figure 31. Global Radiopharmaceuticals for Therapeutic Market Share Forecast by Application (2025-2030)
    Figure 32. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2019-2030)
    Figure 33. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2030)
    Figure 34. North America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2019-2030)
    Figure 35. United States Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 36. Canada Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 37. Mexico Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 38. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2019-2030)
    Figure 39. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2030)
    Figure 40. Europe Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2019-2030)
    Figure 41. Germany Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 42. France Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 43. United Kingdom Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 44. Russia Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 45. Italy Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 46. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2019-2030)
    Figure 47. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2030)
    Figure 48. Asia-Pacific Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region (2019-2030)
    Figure 49. China Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 50. Japan Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 51. South Korea Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 52. India Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 53. Southeast Asia Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 54. Australia Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 55. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2019-2030)
    Figure 56. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2030)
    Figure 57. South America Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2019-2030)
    Figure 58. Brazil Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 59. Argentina Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 60. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Type (2019-2030)
    Figure 61. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Application (2019-2030)
    Figure 62. Middle East and Africa Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Country (2019-2030)
    Figure 63. Turkey Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 64. Saudi Arabia Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 65. UAE Radiopharmaceuticals for Therapeutic Consumption Value (2019-2030) & (USD Million)
    Figure 66. Radiopharmaceuticals for Therapeutic Market Drivers
    Figure 67. Radiopharmaceuticals for Therapeutic Market Restraints
    Figure 68. Radiopharmaceuticals for Therapeutic Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Therapeutic in 2023
    Figure 71. Manufacturing Process Analysis of Radiopharmaceuticals for Therapeutic
    Figure 72. Radiopharmaceuticals for Therapeutic Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma